Daijiworld Media Network - New Delhi
New Delhi, Apr 15: A growing wave of drug-resistant fungi is raising alarm among scientists, with experts warning that the trend could pose serious risks, particularly for patients with weakened immune systems.
The findings come from an international collaboration led by Paul E. Verweij of Radboud University Medical Center, involving 50 researchers from 16 organisations. The study, published in Nature Medicine, highlights the urgent need for coordinated global action.
The research team compiled worldwide data and proposed a five-step strategy to address the growing threat. Their recommendations focus on increasing awareness, strengthening surveillance, improving infection prevention and control, ensuring responsible use of antifungal treatments, and boosting investments in research and healthcare infrastructure.
A key concern raised in the study is that fungal resistance often originates not in hospitals, but in the environment. The widespread use of fungicides in agriculture — many of which are chemically similar to medical antifungal drugs — is accelerating resistance.
According to the researchers, prolonged exposure to these chemicals in farming allows fungi to evolve resistance, which can then spread through the air and infect humans. This process reduces the effectiveness of treatments for severe fungal infections.
The study emphasizes the importance of a “One Health” approach, integrating efforts across human health, agriculture, and environmental sectors to tackle the issue comprehensively.
Experts warn that the consequences are already visible. Drug-resistant strains such as Candida auris in intensive care units and azole-resistant Aspergillosis in the community are increasingly difficult to treat and have been linked to rising mortality.
Verweij cautioned that antifungal resistance must be included in the 2026 Global Action Plan on antimicrobial resistance (AMR), stressing that failure to act decisively could repeat the global crisis seen with antibiotic resistance.
Echoing this concern, Michaela Lackner of the Medical University of Innsbruck pointed out that the dual use of antifungal compounds in agriculture and medicine is accelerating resistance from farm environments to hospital settings.
Researchers argue that aligning agricultural regulations with public health priorities, alongside investment in new antifungal drugs and affordable diagnostic tools, is essential to safeguard both food security and patient care.
The study underscores the urgency of coordinated global measures to prevent drug-resistant fungi from becoming the next major public health crisis.